These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 17657689

  • 1. [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
    Klin Monbl Augenheilkd; 2007 Jul; 224(7):559-66. PubMed ID: 17657689
    [Abstract] [Full Text] [Related]

  • 2. Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
    Nelson M.
    Retina; 2010 Feb; 30(2):380; author reply 380-1. PubMed ID: 20142719
    [No Abstract] [Full Text] [Related]

  • 3. Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
    Shah GK, Sang DN, Hughes MS.
    Retina; 2009 Feb; 29(2):133-48. PubMed ID: 19202423
    [Abstract] [Full Text] [Related]

  • 4. Evolving European guidance on the medical management of neovascular age related macular degeneration.
    Chakravarthy U, Soubrane G, Bandello F, Chong V, Creuzot-Garcher C, Dimitrakos SA, Korobelnik JF, Larsen M, Monés J, Pauleikhoff D, Pournaras CJ, Staurenghi G, Virgili G, Wolf S.
    Br J Ophthalmol; 2006 Sep; 90(9):1188-96. PubMed ID: 16929063
    [Abstract] [Full Text] [Related]

  • 5. [Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
    Klin Monbl Augenheilkd; 2006 Apr; 223(4):271-8. PubMed ID: 16639662
    [Abstract] [Full Text] [Related]

  • 6. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H, Abrams P.
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.
    Aggio FB, Melo GB, Höfling-Lima AL, Eid Farah M.
    Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553
    [No Abstract] [Full Text] [Related]

  • 8. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.
    Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, Recchia FM, American Academy of Ophthalmology.
    Ophthalmology; 2008 Oct; 115(10):1837-46. PubMed ID: 18929163
    [Abstract] [Full Text] [Related]

  • 9. Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration.
    Kaiser PK.
    Curr Med Res Opin; 2007 Mar; 23(3):477-87. PubMed ID: 17355729
    [Abstract] [Full Text] [Related]

  • 10. Antiangiogenic therapy in neovascular age-related macular degeneration.
    Lin RC, Rosenfeld PJ.
    Int Ophthalmol Clin; 2007 Mar; 47(1):117-37. PubMed ID: 17237677
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
    Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY, FOCUS Study Group.
    Arch Ophthalmol; 2006 Nov; 124(11):1532-42. PubMed ID: 17101999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Ciulla TA, Rosenfeld PJ.
    Curr Opin Ophthalmol; 2009 May; 20(3):158-65. PubMed ID: 19417570
    [Abstract] [Full Text] [Related]

  • 19. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.
    Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A.
    Ophthalmology; 2009 Feb; 116(2):286-96. PubMed ID: 19091408
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.